AGL 23.81 Decreased By ▼ -0.54 (-2.22%)
AIRLINK 103.60 Increased By ▲ 0.60 (0.58%)
BOP 5.66 Decreased By ▼ -0.05 (-0.88%)
CNERGY 3.93 Decreased By ▼ -0.03 (-0.76%)
DCL 8.36 Decreased By ▼ -0.14 (-1.65%)
DFML 41.70 Decreased By ▼ -1.29 (-3%)
DGKC 88.30 Decreased By ▼ -0.60 (-0.67%)
FCCL 22.70 No Change ▼ 0.00 (0%)
FFBL 40.88 Increased By ▲ 2.68 (7.02%)
FFL 8.96 Decreased By ▼ -0.15 (-1.65%)
HUBC 160.49 Decreased By ▼ -3.21 (-1.96%)
HUMNL 11.46 Decreased By ▼ -0.34 (-2.88%)
KEL 4.82 Decreased By ▼ -0.03 (-0.62%)
KOSM 4.09 Decreased By ▼ -0.04 (-0.97%)
MLCF 38.60 Increased By ▲ 0.19 (0.49%)
NBP 53.60 Increased By ▲ 0.75 (1.42%)
OGDC 130.60 Decreased By ▼ -2.29 (-1.72%)
PAEL 25.36 Decreased By ▼ -0.29 (-1.13%)
PIBTL 6.25 Decreased By ▼ -0.13 (-2.04%)
PPL 118.90 Decreased By ▼ -0.60 (-0.5%)
PRL 23.95 Decreased By ▼ -0.65 (-2.64%)
PTC 12.92 Increased By ▲ 0.28 (2.22%)
SEARL 59.11 Decreased By ▼ -0.49 (-0.82%)
TELE 7.43 Decreased By ▼ -0.06 (-0.8%)
TOMCL 34.99 Decreased By ▼ -0.16 (-0.46%)
TPLP 8.72 Decreased By ▼ -0.13 (-1.47%)
TREET 15.90 Increased By ▲ 0.10 (0.63%)
TRG 55.95 Decreased By ▼ -1.95 (-3.37%)
UNITY 34.95 Increased By ▲ 0.06 (0.17%)
WTL 1.20 Decreased By ▼ -0.02 (-1.64%)
BR100 8,536 Decreased By -8.5 (-0.1%)
BR30 27,187 Decreased By -204 (-0.74%)
KSE100 79,944 Decreased By -48.3 (-0.06%)
KSE30 25,500 Decreased By -43.9 (-0.17%)

clinical trials

Valneva's COVID-19 shot set for Phase Three trial this month
World

Valneva's COVID-19 shot set for Phase Three trial this month

  • The vaccine, Valneva said, was "generally safe and well tolerated across all dose groups tested, with no safety concerns identified by an independent Data Safety Monitoring Board".
  • "Based on the data assessed, the company has decided to advance the high dose into the phase 3 clinical trial. Other trials, including booster trials, involving antigen sparing doses will also be evaluated," Valneva said.
Updated 06 Apr, 2021 07:29pm
COVID-19: Govt's plan to procure vaccine is insufficient to protect country's 220 million population
Pakistan

COVID-19: Govt's plan to procure vaccine is insufficient to protect country's 220 million population

  • Pakistan is still waiting for the United Nation’s Covax mechanism to receive around 45 million free vaccine doses that will cover country’s 20 percent population
  • Many states including Turkey, Columbia, Bangladesh, Malaysia and India have already struck deals with different COVID-19 vaccine manufacturing firms
  • The Pakistan government has allowed the private sector players to procure vaccine from anywhere in the world and get registered with DRAP
Published 11 Jan, 2021 01:24pm
Sindh Health Secretary gets COVID-19 vaccine shot in clinical trials
Pakistan

Sindh Health Secretary gets COVID-19 vaccine shot in clinical trials

  • “I have presented myself for the vaccine trial as secretary health,” says Dr Kazim Jatoi.
  • Several prominent public figures including Punjab Governor Chaudhry Sarwar and his wife have volunteered to be vaccinated in clinical trials of a Chinese vaccine being conducted in the country.
Published 31 Dec, 2020 03:04pm